Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.

22
Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD

Transcript of Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.

Page 1: Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.

Pathogenesis of HIV disease and markers of

progression

Anjie Zhen, PhD

Page 2: Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.

Summary

• Overview of HIV life cycle

• Overview human immune responses

• HIV pathogenesis

– Acquisition of HIV

– Acute infection

– Chronic infection and markers of progression

– AIDS

Page 3: Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.

Overview of HIV life cycle

HIV life cycle: 1.Binding and Fusion2.Entry3.Reverse transcription4.Integration5.Viral RNA and protein expression6.Assembly and budding7.Maturation

HIV target cells:CD4T cells, Macrohpages, Dendritic cells

Page 4: Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.

Overview of adaptive immunity

Nonspecific Specific

Page 5: Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.

Clearance of viral infection

Page 6: Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.

HIV disease progression – clinical latency

Levels

(S

ep

ara

te S

cale

s)

CD4+ T cell

HIV viral loadCD8+ T cell

Neutralizing Antibodies

Years

AIDS and DeathAcute Asymptomatic

(clinical latency)

4 – 8 weeks

Primary infection

Page 7: Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.

HIV disease progression –Acute infection

Page 8: Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.

HIV disease progression -- Clinical Latency

• During this period of the disease, the immune systems remains competent at handling most infections with opportunistic microbes

• Few or no clinical manifestation.• Steady destruction of CD4+ T

cells and steady decline of circulating blood CD4+ T cells

Page 9: Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.

Mechanism of CD4 T cell depletion in HIV infection

Page 10: Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.

Mechanism of CD4 T cell depletion in HIV infection

• Infection and killing of infected cells only explain part of the T cells loss

• Chronic immune activation and disrupted T cell homeostasis

Page 11: Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.

Stem Cell

MatureT-Cells

HIV Infected Cells

HIV-SpecificT Cell

Expansion ofHIV-Specific

Cells

Killing of HIV Infected Cells

Incomplete Clearance of HIV Infected Cells

and Exhaustion

HIV Specific T Cell Responses

Thymus Periphery

RT

RT

RT

RT

RT

RT

RT

RT

RT

RT

RT

RT

RT

RT

Page 12: Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.

HIV disease progression -- AIDS

• Acquired Immune Deficiency Syndrome:

• Catastrophic breakdown of host defenses, marked increase in viremia and clinical disease.

• CD4+ cell count less than or equal to 200 per microliter

• Clinical Features: • Opportunistic infection • Neoplasms• CNS involvement

Page 13: Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.

HIV disease progression – clinical latency

Levels

(S

ep

ara

te S

cale

s)

CD4+ T cell

HIV viral loadCD8+ T cell

Neutralizing Antibodies

Years

AIDS and DeathAcute Asymptomatic

(clinical latency)

4 – 8 weeks

Primary infection

Page 14: Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.

Markers of HIV disease progression

• CD4 T cell counts

• Viral load

• Markers of immune activation

Page 15: Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.

Markers of disease progression: CD4 cell count

• Major Factor to initiate therapy

– CD4<350: strongly recommended (Data from randomized trials)

– <350<CD4<500: strongly recommended (Data from well

designed non-redomized trials or observational cohort studies)

– Cd4>500: moderately recommended

• Prophylaxis against opportunistic infection is based on CD4

counts

The Lancet Volume 360, Issue 9327 2002 119 - 129

Page 16: Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.

Markers of disease progression: Viral load

• The HIV-1 viral load measurement indicates the number of copies of HIV-1 RNA per milliliter of plasma.

• Viral load is an accurate reflection of the burden of infection and the magnitude of viral replication.

• It is critical in monitoring virologic response to ART.

The Lancet Volume 360, Issue 9327 2002 119 - 129

Page 17: Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.

Prognosis according to CD4 cell count and viral load in the pre-HAART and

HAART eras

The Lancet Volume 360, Issue 9327 2002 119 - 129

Page 18: Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.

Markers of disease progression: Viral load set point

Page 19: Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.

• Chronic immune activation is a characteristic of HIV disease progression.

• Activation markers expressed on cell surface: CD69, CD25, and MHC

class II, CD38, etc.

Markers of disease progression: Immune activation markers

Page 20: Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.

Questions

• List key stages for HIV disease progression?

• While CD4 T cells are progressively

depleted during untreated HIV infection,

what happens to CD8 T cells?

• List one important laboratory marker of HIV

disease progression other than CD4 cell

count

Page 21: Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.

Questions• List key stages for HIV disease progression?

• Acute infection, clinical latency, AIDS.

• While CD4 T cells are progressively depleted during

untreated HIV infection, what happens to CD8 T cells?

• In early HIV infection, CD8 T cells tend to increase in number,

in response to viral infection. However, at advanced stages of

HIV disease, CD8 cells also decline precipitously.

• List one important laboratory marker of HIV disease

progression other than CD4 cell count

• Viral load.

Page 22: Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.

Discussion

• How will effective anti-retroviral

therapy affect our immune

responses?